Revlimid

Celgene expects patent challenge to Revlimid
Yahoo/AP
Wed, 08/25/10 - 12:21 pm
Celgene
patents
Revlimid
cancer
Celgene's Revlimid Marches on
Yahoo/Zacks
Sat, 08/21/10 - 01:35 pm
Celgene
Revlimid
Multiple Myeloma
Celgene Evenly Poised
Yahoo/Zacks.com
Tue, 08/17/10 - 03:17 pm
Celgene
Biogen Idec
companies
Revlimid
Randomized Phase III Study Comparing REVLIMID(R) Plus Melphalan and Prednisone (MPR) Compared to Autologous Stem Cell Transplant Presented at ASCO
MarketWatch
Sun, 06/6/10 - 12:34 pm
Multiple Myeloma
Revlimid
melphalan
autologous stem cell transplant
Celgene
Data from Combination of REVLIMID® and Rituxan® in Untreated Indolent B-Cell Non-Hodgkin's Lymphoma Presented at ASCO
Yahoo/BusinessWire
Sat, 06/5/10 - 09:59 am
non-Hodgkin's lymphoma
Revlimid
Rituxan
Cellgene
Onyx Pharmaceuticals Presents Interim Results of Phase 1b Carfilzomib Combination Trial
Yahoo/PR NewsWire
Sat, 06/5/10 - 09:42 am
Carfilzomib
Revlimid
myeloma
Four Big Areas to Watch at the Upcoming ASCO Meeting, Biotech's Biggest Cancer Confab
BNET Pharma
Mon, 05/24/10 - 08:03 am
Avastin
Nektar
Sunesis
ASCO
cancer
vaccines
personalized medicine
ovarian cancer
Celgene
Revlimid
Rituxan
Roche
Dendreon
Provenge
Celldex
Pfizer
Argos
Plexxikon
Rituxan, Revlimid win in maintenance trials
Fierce Pharma
Fri, 05/21/10 - 11:26 am
Rituxan
Revlimid
Genentech
clinical trials
lymphoma
Roche
Biogen Idec
Celgene (CELG) Is A Top-Growth Biotech Stock; High P/E Multiple And Global Expansion Of Its Myeloma Franchise And REVLIMID Makes It A Top Stock Pick
Yahoo/Wall St. Transcript
Sat, 04/10/10 - 11:39 am
Celgene
Revlimid
Multiple Myeloma
PREVIEW-Celgene R&D day to showcase drugs beyond Revlimid
Reuters
Thu, 04/8/10 - 09:24 am
Celgene
Revlimid
R&D
pipelines
It's the End of Days for Celgene's Multiple-Myeloma Drug Franchise
BNET Pharma
Tue, 02/16/10 - 05:14 pm
Multiple Myeloma
Celgene
Revlimid
Celgene Swings To 4Q Profit, Continues Revlimid Push
WSJ Online
Thu, 01/28/10 - 11:02 am
earnings
Celgene
Revlimid
Celgene's Revlimid meets cancer study goal
Yahoo/AP
Fri, 12/18/09 - 10:43 am
Revlimid
cancer
Celgene
clinical trials
Multiple Myeloma
High Hopes Remain for Celgene's Revlimid
Seeking Alpha
Thu, 12/10/09 - 07:54 am
Celgene
Revlimid
Multiple Myeloma
Early and Often: A Drug Investor's Dream (Celgene)
Motley Fool
Tue, 12/8/09 - 07:24 pm
Revlimid
Celgene
Celgene’s ASH Monday
CNBC
Sat, 12/5/09 - 10:42 am
Celgene
Revlimid
Multiple Myeloma
Celgene: New Studies Expected to Boost Sales
Seeking Alpha
Mon, 11/30/09 - 09:39 pm
drug studies
Celgene
Revlimid
Johnson & Johnson: Good & Bad News
TheStreet.com
Mon, 11/30/09 - 03:37 pm
JNJ
Revlimid
HIV
FDA
Tibotec
Celgene Cancer Pill to Triple Sales on Threat to J&J
Bloomberg
Mon, 11/30/09 - 11:05 am
Celgene
JNJ
cancer
Revlimid
Velcade
Celgene in ASH Abstract Spotlight
TheStreet.com
Tue, 11/10/09 - 10:34 am
Celgene
ASH
Revlimid

Pages